Coxsackievirus B4 and type 1 diabetes pathogenesis: Contribution of animal models

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 7, 2009, Pages 591-603

  Jaidane H ^a,b   Sane F ^a   Gharbi, J ^b   Aouni, M ^b   Romond, M B ^a   Hober, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Animal models; Coxsackievirus B (CV B); Pathogenesis; Type 1 diabetes (T1D)

Indexed keywords

5 [5 [2,6 DICHLORO 4 (4,5 DIHYDRO 2 OXAZOLYL)PHENOXY]PENTYL] 3 METHYLISOXAZOLE;

ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL TRANSPLANTATION; COXSACKIE VIRUS B4; CYTOLYSIS; DIABETOGENESIS; DISEASE MODEL; ENTEROVIRUS INFECTION; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMORAL IMMUNITY; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LYMPHOID TISSUE; MOLECULAR MIMICRY; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RAT STRAIN; REVIEW; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; TRANSGENIC ANIMAL; VIRUS PATHOGENESIS;

ANIMALS; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HUMANS; MICE; RATS;

EID: 70350596084     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.995     Document Type: Review

References (123)

1. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526.
2. Lorenzen T, Pociot F, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994; 37: 321-327. (Pubitemid 24076086)
3. Redondo MJ, Rewers M, Yu L, et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. Br Med J 1999; 318: 698-702. (Pubitemid 29191993)
4. Concannon P, Erlich HA, Julier C, et al. Type 1 Diabetes Genetics Consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005; 54: 2995-3001. (Pubitemid 41401098)
5. Onkamo P, Väanänen S, Karvonen M, Tuomilheto J. Worldwide increase in incidence of Type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-1403. (Pubitemid 30012309)
6. Pitkäniemi J, Onkamo P, Tuomilheto J, Arjas E. Increasing incidence of Type 1 diabetes - role for genes? BMC Genet 2004; 5: 5-18. (Pubitemid 38671567)
7. O'Connell MA, Donath S, Cameron FJ. Major increase in Type 1 diabetes - no support for the Accelerator Hypothesis. Diabet Med 2007; 24: 920-923. (Pubitemid 47093054)
8. Rewers M, Zimmet P. The rising tide of childhood type 1 diabetes - what is the elusive environmental trigger? Lancet 2004; 364: 1645-1647. (Pubitemid 39458129)
9. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003; 1: 151-157.
10. Lammi N, Karvonen M, Tuomilheto J. Do microbes have a causal role in type 1 diabetes? Med Sci Monit 2005; 11: RA63-RA69. (Pubitemid 40445993)
11. Filippi C, von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol 2005; 233: 125-132. (Pubitemid 41074065)
12. Graves PM, Barriga KJ, Norris JM, et al. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 1999; 22: 1694-1697.
13. Jun HS, Yoon JW. A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 8-31. (Pubitemid 36285371)
14. Hindersson M, Elshebani A, Orn A, Tuvemo T, Frisk G. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection. J Clin Virol 2005; 33: 158-167. (Pubitemid 40731505)
15. Mäkelä M, Vaarala O, Hermann R, et al. Enteral virus infections in childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 2006; 27: 54-61. (Pubitemid 44403947)
16. Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 2008; 34: 537-548.
17. Helfand RF, Gary HE, Freeman CY, Anderson LJ, Pallansch MA; Pittsburgh Diabetes Research Group. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. J Infect Dis 1995; 172: 1206-1211.
18. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet Med 1999; 16: 509-513.
19. Chehadeh W, Weill J, Vantyghem MC, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000; 181: 1929-1939. (Pubitemid 30416154)
20. Yin H, Tuvemo T, Frisk G. High frequency of enterovirus RNA in lymphocytes from IDDM children at onset. Diabetologia 2000; 43(Suppl. 1): A96.
21. Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002; 51: 1964-1971. (Pubitemid 34564312)
22. Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gurtler L, Mentel R. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J Med Microbiol 2005; 54: 879-883. (Pubitemid 41216286)
23. Roivainen M, Knip M, Hyöty H, et al. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 1998; 56: 74-78.
24. Lönnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort - The Finnish diabetes Prediction and Prevention Study. Diabetes 2000; 49: 1314-1318. (Pubitemid 30624231)
25. Lönnrot M, Salminen K, Knip M, et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 2000; 61: 214-220.
26. Sadeharju K, Lönnrot M, Kimpimäki T, et al. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia 2001; 44: 818-823. (Pubitemid 32642453)
27. Sadeharju K, Hamalainen AM, Knip M, et al. the Finnish TRIGR Study Group. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol 2003; 132: 271-277. (Pubitemid 36560623)
28. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Neil A. Hospital admission for selected virus infections prior to diabetes mellitus. Diabetes Res Clin Pract 2005; 69: 256-261. (Pubitemid 41140105)
29. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-1179.
30. Dotta F, Censini S, van Halteren AGS, et al. Coxsackie B4 virus infection of beta cells and natural killer insulitis in recent - onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104: 5115-5120. (Pubitemid 47186185)
31. Chehadeh W, Kerr-Conte J, Pattou F, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000; 74: 10153-10164. (Pubitemid 30780824)
32. Elshebani A, Olsson A, Westman J, Tuvemo T, Korsgren O, Frisk G. Effects on isolated pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 2007; 124: 193-203. (Pubitemid 46216572)
33. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19: 80-94. (Pubitemid 43157648)
34. Roivainen M. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int J Biochem Cell Biol 2006; 38: 721-725. (Pubitemid 43363408)
35. Lang J, Bellgrau D. Animal models of type 1 diabetes: genetics and immunological function. Adv Exp Med Biol 2004; 552: 91-116. (Pubitemid 40090326)
36. Eisenbarth GS. Animal models of type 1 diabetes: Genetics and immunological function. In Type 1 Diabetes: Molecular, Cellular and Clinical Immunology, Eisenbarth GS (ed.) Barbara Davis Center for Childhood Diabetes: 2005; http://www.uchsc.edu/misc/diabetes/oxch3.html.
37. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29: 1-13. (Pubitemid 10185796)
38. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F. Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction. Diabetologia 1984; 27: 113-115. (Pubitemid 14096726)
39. Maruyama T, Takei I, Yanagawa T, et al. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin induced diabetic mice. Diabetes Res 1988; 7: 93-96. (Pubitemid 18178059)
40. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13: 179-200.
41. Oldstone MB. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 1988; 239: 500-502. (Pubitemid 18084314)
42. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49: 708-711.
43. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5: 601-604.
44. Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB. The spontaneously diabetic Wistar rat: metabolic and morphologic studies. Diabetes 1977; 26: 100-112.
45. Bellgrau D, Naji A, Silvers WK, Markmann JF, Barker CF. Spontaneous diabetes in BB rats: evidence for T cell dependent immune response defect. Diabetologia 1982; 23: 359-364.
46. Woda BA, Like AA, Padden C, McFadden ML. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol 1986; 136: 856-859. (Pubitemid 16146366)
47. Like AA, Guberski DL, Butler L. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes 1991; 40: 259-262.
48. Crisa L, Mordes JP, Rossini AA. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 1992; 8: 4-37.
49. Colle E, Fuks A, Poussier P, Edouard P, Guttman RD. Polygenic nature of spontaneous diabetes in the rat: Permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. Diabetes 1992; 41: 1617-1623.
50. Payne F, Smyth DJ, Pask R, et al. Haplotype tag single nucleotide polymorphism analysis of the human orthologues of the rat type 1 diabetes genes Ian4 (Lyp/Iddm1) and Cblb. Diabetes 2004; 53: 505-509. (Pubitemid 38174570)
51. Guberski DL, Thomas VA, Shek WR, et al. Induction of type 1 diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1992; 254: 1010-1013.
52. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia. Diabetes 1991; 40: 1375-1381.
53. Yokoi N, Kanazawa M, Kitada K, et al. A non-MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes-Prone rat. J Clin Invest 1997; 100: 2015-2021. (Pubitemid 27459355)
54. Yokoi N, Komeda K, Wang HY, et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 2002; 31: 391-394. (Pubitemid 35154448)
55. Komeda K, Noda M, Terao K, Kuzuya N, Kanazawa M, Kanazawa Y. Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats. Endocr J 1998; 45: 737-744. (Pubitemid 29082595)
56. Lenzen S, Tiedge M, Elsner M, et al. The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 2001; 44: 1189-1196. (Pubitemid 32835513)
57. Jorns A, Kubat B, Tiedge M, et al. Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch 2004; 444: 183-189. (Pubitemid 38315298)
58. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989; 86: 8000-8004. (Pubitemid 19265307)
59. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997; 186: 1663-1676. (Pubitemid 27506280)
60. Graser RT, DiLorenzo TP, Wang F, et al. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 2000; 164: 3913-3918. (Pubitemid 30169851)
61. Yang Y, Santamaria P. Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice. Diabetologia 2003; 46: 1447-1464. (Pubitemid 37518566)
62. Hutton JC, Eisenbarth GS. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci USA 2003; 100: 8626-8628.
63. Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 2004; 173: 6727-6734. (Pubitemid 39541058)
64. von Herrath MG, Evans CF, Horwitz MS, Oldstone MB. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev 1996; 152: 111-143. (Pubitemid 26362755)
65. Pechhold K, Karges W, Blum C, Boehm BO, Harlan DM. Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes. J Autoimmun 2003; 20: 1-13. (Pubitemid 36207623)
66. Fugger L. Human autoimmunity genes in mice. Curr Opin Immunol 2000; 12: 698-703.
67. Wen L, Wong FS, Tang J, et al. Invivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med 2000; 191: 97-104. (Pubitemid 30043651)
68. LeCompte PM, Steinke J, Soeldner JS, Renold AE. Changes in the islets of Langerhans in cows injected with heterologous and homologous insulin. Diabetes 1966; 15: 586-596.
69. Grodsky GM, Feldman R, Toreson WE, Lee JC. Diabetes mellitus in rabbits immunized with insulin. Diabetes 1966; 15: 579-585.
70. Abiru N, Maniatis AK, Yu L, et al. Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. Diabetes 2001; 50: 1274-1281. (Pubitemid 32500159)
71. Larsen MO, Rolin B. Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 2004; 45: 303-313.
72. Webb SR, Loria RM, Madge GE, Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 1976; 143: 1239-1248.
73. Loria RM, Montgomery LB, Corey LA, Chinchilli VM. Influence of diabetes mellitus heredity on susceptibility to coxsackievirus B4. Arch Virol 1984; 81: 251-262. (Pubitemid 14066250)
74. Loria RM, Montgomery LB, Tuttle-Fuller N, Gregg HM, Chinchilli VM. Genetic predisposition to diabetes mellitus is associated with impaired humoral immunity to coxsackievirus B4. Diabetes Res Clin Pract 1986; 2: 91-96. (Pubitemid 17233403)
75. Yoon JW, Onodera T, Notkins AL. Virus induced diabetes mellitus: beta cell damage and insulin dependent hyperglycemia in mice infected with coxsackie B4. J Exp Med 1978; 148: 1068-1080. (Pubitemid 9034273)
76. Yoon JW, London WT, Curfman BL, Brown RL, Notkins AL. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986; 35: 712-716.
77. Vella C, Brown CL, McCarthy DA. Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection. J Gen Virol 1992; 73: 1387-1394.
78. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses - some recent developments. Diabetologia 1993; 36: 687-695.
79. Al-Hello H, Davydova B, Smura T, et al. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo. J Med Virol 2005; 75: 566-574. (Pubitemid 40293524)
80. Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. Group B Coxsackievirus diabetogenic phenotype correlates with replication efficacy. J Virol 2006; 80: 5637-5643. (Pubitemid 43752810)
81. Hyöty H. Enterovirus infections and type 1 diabetes. Ann Med 2002; 34: 138-147.
82. Cheung PK, Yuan J, Zhang HM, et al. Specific interactions of mouse organ proteins with the 5′untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism. J Med Virol 2005; 77: 414-424. (Pubitemid 41395872)
83. See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J Infect Dis 1995; 171: 1131-1138.
84. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004; 329: 381-394. (Pubitemid 39423987)
85. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
86. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994; 43: 1260-1266. (Pubitemid 24361194)
87. Härkönen T, Lankinen H, Davydova B, Hovi T, Roivainen M. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002; 66: 340-350. (Pubitemid 34111775)
88. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994; 180: 1979-1984. (Pubitemid 24328590)
89. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4: 781-785. (Pubitemid 28331018)
90. Horwitz MS, Fine C, Ilic A, Sarvetnick N. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. J Autoimmun 2001; 16: 211-217. (Pubitemid 32566109)
91. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 2002; 109: 79-87. (Pubitemid 34052544)
92. Horwitz MS, Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol Rev 1999; 169: 241-253.
93. Horwitz MS, Ilic A, Fine C, Balasa B, Sarvetnick N. Coxsackieviral- mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 2004; 110: 134-144. (Pubitemid 38296703)
94. Berger MM, See DM, Aymard M, Lina B. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin Diagn Virol 1998; 9: 141-143. (Pubitemid 28266709)
95. Dotta F, Censini S, van Halteren AG, et al Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104: 5115-5120. (Pubitemid 47186185)
96. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52: 1143-1151.
97. Roivainen M, Klingel K. Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 2009; 52: 995-996.
98. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology 2003; 314: 510-520. (Pubitemid 37209978)
99. Bopegamage SA, Petrovicová A. Tumour necrosis factor alfa and glucose levels in sera of mice infected with coxsackie B4 and A7 viruses. Acta Virol 1998; 42: 409-411. (Pubitemid 29180558)
100. Christen U, Benke D, Wolfe T, et al. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 2004; 113: 74-84. (Pubitemid 38541634)
101. Christen U, Wolfe T, Möhrle U, et al. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 2001; 166: 7023-7032. (Pubitemid 32525571)
102. von Herrath M. Can we learn from viruses how to prevent type 1 diabetes?: The role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies. Diabetes 2009; 58: 2-11.
103. Yap IS, Giddings G, Pocock E, Chantler JK. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol 2003; 84: 3051-3068. (Pubitemid 37336789)
104. Serreze DV, Wasserfall C, Ottendorfer EW, et al. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma-interferon. J Virol 2005; 79: 1045-1052. (Pubitemid 40053888)
105. Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3: 373-382. (Pubitemid 34308626)
106. Flodström-Tullberg M, Hultcrantz M, Stotland A, et al. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 2005; 174: 1171-1177.
107. Chatterjee NK, Nejman C. Insulin mRNA content in pancreatic beta cells of coxsackievirus B4-induced diabetic mice. Mol Cell Endocrinol 1988; 55: 193-202. (Pubitemid 18055209)
108. Gerling I, Nejman C, Chatterjee NK. Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes 1988; 37: 1419-1425. (Pubitemid 19035995)
109. Gerling I, Chatterjee NK, Nejman C. Coxsackievirus B4-induced development of antibodies to 64,000-Mr islet autoantigen and hyperglycemia in mice. Autoimmunity 1991; 10: 49-56.
110. Gerling I, Chatterjee NK. Lack of 64,000-M(r) islet autoantigen overexpression and antibody development following coxsackievirus B4 infection in diabetes-resistant mice. Autoimmunity 1993; 14: 197-203. (Pubitemid 23184818)
111. Chatterjee NK, Gerling I, Nejman C. Pancreatic D-cell disorder in coxsackievirus B4-induced diabetic mice. Mol Cell Endocrinol 1989; 67: 39-45. (Pubitemid 19262894)
112. Ilbäck NG, Benyamin G, Lindh U, Fohlman J, Friman G. Trace element changes in the pancreas during viral infection in mice. Pancreas 2003; 26: 190-196. (Pubitemid 36278308)
113. Frisk P, Tallkvist J, Gadhasson IL, Blomberg J, Friman G, Ilbäck NG. Coxsackievirus B3 infection affects metal-binding/transporting proteins and trace elements in the pancreas in mice. Pancreas 2007; 35: e37-e44. (Pubitemid 47482534)
114. Jaïdane H, Gharbi J, Lobert PE, et al. Prolonged viral DRNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiol Immunol 2006; 50: 971-974. (Pubitemid 44974653)
115. Jaïdane H, Gharbi J, Lobert PE, et al. Infection of primary cultures of murine splenic and thymic cells with Coxsackievirus B4. Microbiol Immunol 2008; 52: 40-46.
116. Brilot F, Jaïdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J Med Virol 2008; 80: 659-666. (Pubitemid 351358564)
117. Chatterjee NK, Hou J, Dockstader P, Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J Med Virol 1992; 38: 124-131.
118. Tracy S, Dresher KM, Chapman NM, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002; 76: 12097-12111. (Pubitemid 35304309)
119. Filippi CM, von Herrath M. Viral trigger for type 1 diabetes. Pros and cons. Diabetes 2008; 57: 2863-2871.
120. Davydova B, Härkönen T, Kaialainen S, Hovi T, Vaarala O, Roivainen M. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 2003; 69: 510-520. (Pubitemid 36249865)
121. See DM, Tilles JG. WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus. Antimicrob Agents Chemother 1993; 37: 1593-1598.
122. Bopegamage S, Kovacova J, Vargova A, et al. Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 2005; 86: 3271-3280. (Pubitemid 41685159)
123. The Juvenile Diabetes Research Foundation : The Network for Pancreatic Organ Donors with Diabetes. www.jdrfnpod.org.